Cargando…
In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795542/ https://www.ncbi.nlm.nih.gov/pubmed/26987059 http://dx.doi.org/10.1371/journal.pone.0151940 |
_version_ | 1782421618237112320 |
---|---|
author | Pohle, Susanne Baty, Florent Brutsche, Martin |
author_facet | Pohle, Susanne Baty, Florent Brutsche, Martin |
author_sort | Pohle, Susanne |
collection | PubMed |
description | Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002–2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization. |
format | Online Article Text |
id | pubmed-4795542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47955422016-03-23 In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 Pohle, Susanne Baty, Florent Brutsche, Martin PLoS One Research Article Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002–2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization. Public Library of Science 2016-03-17 /pmc/articles/PMC4795542/ /pubmed/26987059 http://dx.doi.org/10.1371/journal.pone.0151940 Text en © 2016 Pohle et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Pohle, Susanne Baty, Florent Brutsche, Martin In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title | In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title_full | In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title_fullStr | In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title_full_unstemmed | In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title_short | In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 |
title_sort | in-hospital disease burden of sarcoidosis in switzerland from 2002 to 2012 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795542/ https://www.ncbi.nlm.nih.gov/pubmed/26987059 http://dx.doi.org/10.1371/journal.pone.0151940 |
work_keys_str_mv | AT pohlesusanne inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012 AT batyflorent inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012 AT brutschemartin inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012 |